1. Targeted Combination Therapies: A New Frontier in the Treatment of TP53 and KRAS Mutation-Associated Cancers
   Robert B. Kargbo, 2024, ACS Medicinal Chemistry Letters CrossRef
2. Inhibition of the RAF/MEK/ERK Signaling Cascade in Pancreatic Cancer: Recent Advances and Future Perspectives
   Christos Adamopoulos et al, 2024, International Journal of Molecular Sciences CrossRef